|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Hydrocision's Patent Portfolio is Expanding: Twenty-seventh Patent is Allowed
12/10/2007 10:23:41 AM
BILLERICA, Mass.--(BUSINESS WIRE)--HydroCision Inc. (www.hydrocision.com) announced today that its patent application U.S. 2004/228736 for its fluidjet products has been allowed and will be its 27th patent to issue worldwide. Fluidjet products using HydroCision’s proprietary technology have now been successfully used in more than 15,000 spine, arthroscopic, and wound debridement procedures combined –firmly establishing HydroSurgery as a major platform in surgery. The Company’s family of fluidjet products, which is covered in its expanding worldwide intellectual property portfolio, empowers surgeons to simultaneously cut, ablate, and remove hard and soft tissue quickly, safely, and effectively without the collateral thermal or mechanical trauma of other surgical modalities.
|
|
|
|
|
|
|
|
|
|
|